Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
20 July 2017
|
| In: |
European journal of cancer
Year: 2017, Volume: 83, Pages: 142-145 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2017.06.020 |
| Online Access: | Verlag, Pay-per-use, Volltext: http://dx.doi.org/10.1016/j.ejca.2017.06.020 Verlag, Pay-per-use, Volltext: http://www.sciencedirect.com/science/article/pii/S0959804917310717 
|
| Author Notes: | Selma Ugurel, Felix Kiecker, Stefan Fröhling, Axel Wetter, Agnes Bankfalvi, Antje Sucker, Lisa Zimmer, Elisabeth Livingstone, Alexander Roesch, Jürgen C. Becker, Dirk Schadendorf |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581253516 | ||
| 003 | DE-627 | ||
| 005 | 20251111100529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180924s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2017.06.020 |2 doi | |
| 035 | |a (DE-627)1581253516 | ||
| 035 | |a (DE-576)511253516 | ||
| 035 | |a (DE-599)BSZ511253516 | ||
| 035 | |a (OCoLC)1341019235 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ugurel, Selma |d 1971- |e VerfasserIn |0 (DE-588)122030923 |0 (DE-627)081693532 |0 (DE-576)293057567 |4 aut | |
| 245 | 1 | 0 | |a Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma |c Selma Ugurel, Felix Kiecker, Stefan Fröhling, Axel Wetter, Agnes Bankfalvi, Antje Sucker, Lisa Zimmer, Elisabeth Livingstone, Alexander Roesch, Jürgen C. Becker, Dirk Schadendorf |
| 264 | 1 | |c 20 July 2017 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.09.2018 | ||
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 83(2017), Seite 142-145 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma |
| 773 | 1 | 8 | |g volume:83 |g year:2017 |g pages:142-145 |g extent:4 |a Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2017.06.020 |x Verlag |x Resolving-System |z Pay-per-use |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0959804917310717 |x Verlag |z Pay-per-use |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180924 | ||
| 993 | |a Editorial | ||
| 994 | |a 2017 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 11 |y j | ||
| 998 | |g 120890046 |a Fröhling, Stefan |m 120890046:Fröhling, Stefan |d 50000 |e 50000PF120890046 |k 0/50000/ |p 3 | ||
| 998 | |g 122030923 |a Ugurel, Selma |m 122030923:Ugurel, Selma |d 60000 |e 60000PU122030923 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1581253516 |e 3026444782 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Selma Ugurel, Felix Kiecker, Stefan Fröhling, Axel Wetter, Agnes Bankfalvi, Antje Sucker, Lisa Zimmer, Elisabeth Livingstone, Alexander Roesch, Jürgen C. Becker, Dirk Schadendorf"]},"note":["Gesehen am 24.09.2018"],"person":[{"role":"aut","family":"Ugurel","display":"Ugurel, Selma","given":"Selma"},{"display":"Fröhling, Stefan","given":"Stefan","family":"Fröhling","role":"aut"},{"family":"Schadendorf","role":"aut","display":"Schadendorf, Dirk","given":"Dirk"}],"recId":"1581253516","physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1016/j.ejca.2017.06.020"],"eki":["1581253516"]},"title":[{"title":"Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma","title_sort":"Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"20 July 2017"}],"relHost":[{"origin":[{"publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]},"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"recId":"266883400","titleAlt":[{"title":"EJC online"}],"disp":"Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanomaEuropean journal of cancer","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}],"pubHistory":["28.1992 -"],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"part":{"extent":"4","pages":"142-145","text":"83(2017), Seite 142-145","year":"2017","volume":"83"},"language":["eng"]}]} | ||
| SRT | |a UGURELSELMFULMINANTR2020 | ||